Analysts Anticipate Artivion, Inc. (NYSE:AORT) to Announce $0.09 Earnings Per Share

Analysts forecast that Artivion, Inc. (NYSE:AORTGet Rating) will report earnings of $0.09 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Artivion’s earnings. Artivion posted earnings of ($0.06) per share in the same quarter last year, which would suggest a positive year over year growth rate of 250%. The business is scheduled to issue its next earnings report on Monday, January 1st.

On average, analysts expect that Artivion will report full-year earnings of ($0.05) per share for the current financial year, with EPS estimates ranging from ($0.14) to $0.05. For the next fiscal year, analysts forecast that the business will report earnings of $0.38 per share, with EPS estimates ranging from $0.30 to $0.46. Zacks’ EPS calculations are a mean average based on a survey of research firms that follow Artivion.

Artivion (NYSE:AORTGet Rating) last posted its earnings results on Thursday, May 5th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.12) by $0.15. Artivion had a positive return on equity of 3.08% and a negative net margin of 4.95%.

Several analysts have weighed in on the company. Zacks Investment Research upgraded Artivion from a “sell” rating to a “hold” rating in a research report on Wednesday, February 23rd. Stifel Nicolaus initiated coverage on Artivion in a research report on Thursday, March 3rd. They issued a “buy” rating and a $30.00 price objective on the stock. Needham & Company LLC cut their target price on shares of Artivion from $39.00 to $30.00 and set a “buy” rating for the company in a research report on Friday, February 18th. Finally, TheStreet lowered shares of Artivion from a “c-” rating to a “d” rating in a report on Friday, February 18th.

Shares of AORT opened at $16.41 on Monday. Artivion has a 1 year low of $15.44 and a 1 year high of $31.78. The company has a debt-to-equity ratio of 1.05, a quick ratio of 3.93 and a current ratio of 5.71. The stock has a 50 day moving average price of $20.55. The stock has a market capitalization of $659.71 million, a price-to-earnings ratio of -42.08 and a beta of 1.48.

Artivion Company Profile (Get Rating)

Artivion Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo.

Recommended Stories

Get a free copy of the Zacks research report on Artivion (AORT)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Artivion (NYSE:AORT)

Receive News & Ratings for Artivion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artivion and related companies with's FREE daily email newsletter.